A detailed history of Princeton Capital Management LLC transactions in Incyte Corp stock. As of the latest transaction made, Princeton Capital Management LLC holds 10,879 shares of INCY stock, worth $746,408. This represents 0.23% of its overall portfolio holdings.

Number of Shares
10,879
Previous 12,250 11.19%
Holding current value
$746,408
Previous $769,000 19.51%
% of portfolio
0.23%
Previous 0.31%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$56.55 - $66.59 $77,530 - $91,294
-1,371 Reduced 11.19%
10,879 $619,000
Q4 2023

Feb 08, 2024

SELL
$52.16 - $64.19 $147,769 - $181,850
-2,833 Reduced 18.78%
12,250 $769,000
Q3 2023

Nov 13, 2023

SELL
$57.77 - $65.93 $9,127 - $10,416
-158 Reduced 1.04%
15,083 $871,000
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $45,224 - $56,028
-742 Reduced 4.64%
15,241 $948,000
Q1 2023

May 01, 2023

SELL
$70.23 - $86.01 $29,988 - $36,726
-427 Reduced 2.6%
15,983 $1.16 Million
Q4 2022

Jan 31, 2023

SELL
$67.18 - $84.11 $32,515 - $40,709
-484 Reduced 2.86%
16,410 $1.32 Million
Q3 2022

Nov 10, 2022

BUY
$66.18 - $82.86 $43,480 - $54,439
657 Added 4.05%
16,894 $1.13 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $397 - $499
-6 Reduced 0.04%
16,237 $1.23 Million
Q1 2022

May 11, 2022

SELL
$66.02 - $79.71 $85,627 - $103,383
-1,297 Reduced 7.39%
16,243 $1.29 Million
Q4 2021

Feb 09, 2022

BUY
$63.34 - $74.11 $22,359 - $26,160
353 Added 2.05%
17,540 $1.29 Million
Q3 2021

Nov 10, 2021

BUY
$68.67 - $84.02 $77,597 - $94,942
1,130 Added 7.04%
17,187 $1.18 Million
Q2 2021

Aug 11, 2021

BUY
$79.87 - $87.53 $67,490 - $73,962
845 Added 5.55%
16,057 $1.35 Million
Q1 2021

May 12, 2021

BUY
$76.02 - $100.5 $53,214 - $70,350
700 Added 4.82%
15,212 $1.24 Million
Q4 2020

Feb 11, 2021

SELL
$80.74 - $97.7 $189,254 - $229,008
-2,344 Reduced 13.91%
14,512 $1.26 Million
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $111,781 - $144,132
1,314 Added 8.45%
16,856 $1.51 Million
Q2 2020

Aug 10, 2020

BUY
$74.18 - $108.93 $276,320 - $405,764
3,725 Added 31.52%
15,542 $1.62 Million
Q1 2020

May 13, 2020

BUY
$63.18 - $85.97 $110,122 - $149,845
1,743 Added 17.3%
11,817 $1.14 Million
Q4 2019

Feb 12, 2020

BUY
$73.04 - $95.72 $171,644 - $224,942
2,350 Added 30.42%
10,074 $747,000
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $51,046 - $60,650
701 Added 9.98%
7,724 $573,000
Q2 2019

Aug 12, 2019

BUY
$73.52 - $88.7 $55,213 - $66,613
751 Added 11.97%
7,023 $597,000
Q1 2019

May 02, 2019

SELL
$63.56 - $88.17 $18,368 - $25,481
-289 Reduced 4.4%
6,272 $539,000
Q4 2018

Feb 13, 2019

SELL
$58.5 - $69.94 $239,323 - $286,124
-4,091 Reduced 38.41%
6,561 $417,000
Q3 2018

Nov 08, 2018

SELL
$61.75 - $74.23 $23,526 - $28,281
-381 Reduced 3.45%
10,652 $736,000
Q2 2018

Aug 02, 2018

SELL
$60.85 - $83.98 $9,796 - $13,520
-161 Reduced 1.44%
11,033 $739,000
Q1 2018

May 03, 2018

BUY
$83.06 - $100.98 $218,115 - $265,173
2,626 Added 30.65%
11,194 $933,000
Q4 2017

Feb 12, 2018

BUY
$93.56 - $116.6 $801,622 - $999,028
8,568
8,568 $811,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.3B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.